These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 23862614)
1. Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model. Lueshen E; Venugopal I; Kanikunnel J; Soni T; Alaraj A; Linninger A Nanomedicine (Lond); 2014; 9(8):1155-69. PubMed ID: 23862614 [TBL] [Abstract][Full Text] [Related]
2. Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders. Lueshen E; Venugopal I; Soni T; Alaraj A; Linninger A J Biomed Nanotechnol; 2015 Feb; 11(2):253-61. PubMed ID: 26349301 [TBL] [Abstract][Full Text] [Related]
3. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712 [TBL] [Abstract][Full Text] [Related]
4. Intrathecal magnetic drug targeting for localized delivery of therapeutics in the CNS. Venugopal I; Habib N; Linninger A Nanomedicine (Lond); 2017 Apr; 12(8):865-877. PubMed ID: 28339319 [TBL] [Abstract][Full Text] [Related]
5. Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery. Kralj S; Potrc T; Kocbek P; Marchesan S; Makovec D Curr Med Chem; 2017; 24(5):454-469. PubMed ID: 27528059 [TBL] [Abstract][Full Text] [Related]
6. Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia. Kim DH; Kim KN; Kim KM; Lee YK J Biomed Mater Res A; 2009 Jan; 88(1):1-11. PubMed ID: 18257079 [TBL] [Abstract][Full Text] [Related]
7. Analysis of trajectories for targeting of magnetic nanoparticles in blood vessels. Heidsieck A; Vosen S; Zimmermann K; Wenzel D; Gleich B Mol Pharm; 2012 Jul; 9(7):2029-38. PubMed ID: 22663555 [TBL] [Abstract][Full Text] [Related]
8. Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting. Avilés MO; Mangual JO; Ebner AD; Ritter JA Int J Pharm; 2008 Sep; 361(1-2):202-8. PubMed ID: 18573319 [TBL] [Abstract][Full Text] [Related]
9. Investigation of magnetically driven passage of magnetic nanoparticles through eye tissues for magnetic drug targeting. Zahn D; Klein K; Radon P; Berkov D; Erokhin S; Nagel E; Eichhorn M; Wiekhorst F; Dutz S Nanotechnology; 2020 Dec; 31(49):495101. PubMed ID: 32946423 [TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticle-based drug delivery for cancer therapy. Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592 [TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung. Tewes F; Ehrhardt C; Healy AM Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690 [TBL] [Abstract][Full Text] [Related]
12. Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting. Richter H; Wiekhorst F; Schwarz K; Lyer S; Tietze R; Alexiou Ch; Trahms L Phys Med Biol; 2009 Sep; 54(18):N417-24. PubMed ID: 19700820 [TBL] [Abstract][Full Text] [Related]
13. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation. Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360 [TBL] [Abstract][Full Text] [Related]
14. [Magnetic dipole interaction of endogenous magnetic nanoparticles with magnetoliposomes for targeted drug delivery]. Gorobets SV; Gorobets OIu; Chizh IuM; Siveniuk DV Biofizika; 2013; 58(3):488-94. PubMed ID: 24159818 [TBL] [Abstract][Full Text] [Related]
15. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable polyelectrolyte/magnetite capsules for MR imaging and magnetic targeting of tumors. Svenskaya Y; Garello F; Lengert E; Kozlova A; Verkhovskii R; Bitonto V; Ruggiero MR; German S; Gorin D; Terreno E Nanotheranostics; 2021; 5(3):362-377. PubMed ID: 33850694 [No Abstract] [Full Text] [Related]
17. Computational Assessment of Unsteady Flow Effects on Magnetic Nanoparticle Targeting Efficiency in a Magnetic Stented Carotid Bifurcation Artery. Hewlin RL; Smith M; Kizito JP Cardiovasc Eng Technol; 2023 Oct; 14(5):694-712. PubMed ID: 37723333 [TBL] [Abstract][Full Text] [Related]
18. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Polyak B; Friedman G Expert Opin Drug Deliv; 2009 Jan; 6(1):53-70. PubMed ID: 19236208 [TBL] [Abstract][Full Text] [Related]
19. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs. López-Viota M; El-Hammadi MM; Cabeza L; Prados J; Melguizo C; Ruiz Martinez MA; Arias JL; Delgado ÁV AAPS PharmSciTech; 2017 Nov; 18(8):3042-3052. PubMed ID: 28508129 [TBL] [Abstract][Full Text] [Related]
20. Drug embedded PVP coated magnetic nanoparticles for targeted killing of breast cancer cells. Rose PA; Praseetha PK; Bhagat M; Alexander P; Abdeen S; Chavali M Technol Cancer Res Treat; 2013 Oct; 12(5):463-72. PubMed ID: 23547975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]